LIVE QUOTE
Elevance Health Inc. ELV
Healthcare · Medical - Healthcare Plans · NYSE
$418.15
Market Cap$100.0B
P/E Ratio14.0
Dividend Yield1.30%
Beta0.68
Employees104,200

Investment Thesis

. A more favorable entry point could present itself if the stock dips below $370, which would provide an attractive risk/reward profile.

Competitive Moat

Elevance Health benefits from significant economies of scale and strong regulatory advantages, which create substantial barriers for new entrants. The company's extensive network of healthcare providers and partnerships enhances its value proposition, fostering customer loyalty and high switching costs. This competitive moat is durable over the next 5-10 years, although potential threats include the rise of digital health disruptors and regulatory changes that could impact profitability. Maintaining a strong brand reputation will be crucial to fend off these threats.

Growth Engine

Future revenue growth for Elevance is expected to stem from the expanding total addressable market (TAM) in healthcare, projected to grow significantly due to increasing demand for personalized health services and wellness solutions. The company is actively pursuing organic growth through the enhancement of its digital health offerings while also exploring strategic acquisitions to expand its service capabilities and geographic reach. Elevance is gaining market share in a fragmented industry, driven by its innovative approach to integrated healthcare solutions.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Baupost Group
7.3%
INCREASED +0.5%
Morningstar Investor
Analyst ratings, fair value, moat
Research ELV
Robinhood
$0 commission trades
Trade ELV
Webull
Extended-hours, options, charts
Trade ELV
TradingView
Advanced charts & screeners
Chart ELV
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-06-08, Elevance Health Inc. (ELV) has a P/E ratio of N/A, which may indicate that the stock is not currently valued in a traditional earnings context. Additionally, without a market cap provided, it's difficult to assess its relative size within the healthcare sector, making it essential for investors to consider further analysis before making a decision.
As of 2026-06-08, Elevance Health Inc. does not currently pay a dividend, which may be a consideration for income-focused investors.
Elevance Health Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry, providing a range of health benefits and services.
As of 2026-06-08, the market cap for Elevance Health Inc. is not available, making it challenging to classify the company within traditional market cap categories.
Elevance Health Inc. faces competition from several companies in the healthcare plans industry, including UnitedHealth Group and Cigna, which also offer a variety of health benefits and services.
FAQ generated 2026-06-08

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms